Bellini Carcinoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma (NCT06302569) | Giuseppe Procopio | 2025-05-30 |
Track Bellini Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.